• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植术后发生中毒性表皮坏死松解症可能与头孢哌酮钠舒巴坦钠有关。

Toxic epidermal necrolysis following heart transplantation may caused by cefoperazone sodium and sulbactam sodium.

机构信息

Department of Cardiac Surgery Intensive Care Unit, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.

Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510080, China.

出版信息

J Cardiothorac Surg. 2024 Sep 23;19(1):542. doi: 10.1186/s13019-024-03025-x.

DOI:10.1186/s13019-024-03025-x
PMID:39307887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11418188/
Abstract

BACKGROUND

The outcome of heart transplantation is significantly affected by perioperative infections. Individualised immunosuppression strategies are essential to reduce the risk of such infections.

CASE PRESENTATION

We report the successful management of a 56-year-old male patient diagnosed with dilated cardiomyopathy who underwent heart transplantation. During the perioperative period, the patient was prescribed cefoperazone sodium and sulbactam sodium, which induced a severe skin reaction: toxic epidermal necrolysis (TEN). The patient was treated with prednisone, immunoglobulins, etanercept, and other active immunomodulatory measures, together with an individualised anti-rejection regimen and physical therapy. The systemic rash resolved within a month, and the patient was successfully discharged after surgery.

CONCLUSION

Effective management of heart transplantation necessitates balancing immunosuppression and infection prevention. Individualised immunosuppressive strategies are critical for optimal clinical outcomes.

摘要

背景

心脏移植的结果受围手术期感染的显著影响。个体化的免疫抑制策略对于降低此类感染的风险至关重要。

病例介绍

我们报告了一位成功管理的 56 岁男性扩张型心肌病患者,他接受了心脏移植。在围手术期,该患者被开处头孢哌酮钠和舒巴坦钠,这引发了严重的皮肤反应:中毒性表皮坏死松解症(TEN)。该患者接受了泼尼松、免疫球蛋白、依那西普和其他主动免疫调节措施,以及个体化的抗排斥方案和物理治疗。全身性皮疹在一个月内消退,患者在手术后成功出院。

结论

有效管理心脏移植需要平衡免疫抑制和感染预防。个体化的免疫抑制策略对于获得最佳临床结果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/8f2fc2e48a45/13019_2024_3025_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/a721bf39bd8f/13019_2024_3025_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/df991105b847/13019_2024_3025_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/83b4330a0b68/13019_2024_3025_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/4eb8b31e4cc9/13019_2024_3025_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/8f2fc2e48a45/13019_2024_3025_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/a721bf39bd8f/13019_2024_3025_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/df991105b847/13019_2024_3025_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/83b4330a0b68/13019_2024_3025_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/4eb8b31e4cc9/13019_2024_3025_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f716/11418188/8f2fc2e48a45/13019_2024_3025_Fig5_HTML.jpg

相似文献

1
Toxic epidermal necrolysis following heart transplantation may caused by cefoperazone sodium and sulbactam sodium.心脏移植术后发生中毒性表皮坏死松解症可能与头孢哌酮钠舒巴坦钠有关。
J Cardiothorac Surg. 2024 Sep 23;19(1):542. doi: 10.1186/s13019-024-03025-x.
2
A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.头孢曲松/舒巴坦与头孢哌酮/舒巴坦治疗呼吸道和尿路感染的多中心临床研究。
Ann Clin Microbiol Antimicrob. 2013 Dec 9;12:38. doi: 10.1186/1476-0711-12-38.
3
A case report of rash induced by cefoperazone sodium and sulbactam sodium plus metronidazole sodium chloride combined with morphine hydrochloride.头孢哌酮钠舒巴坦钠与甲硝唑氯化钠联合盐酸吗啡致皮疹1例报告
Ann Palliat Med. 2020 Nov;9(6):4377-4383. doi: 10.21037/apm-20-2192.
4
A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.一名患有史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的2岁女孩接受了静脉注射免疫球蛋白治疗。
Pediatr Dermatol. 2005 Jul-Aug;22(4):317-20. doi: 10.1111/j.1525-1470.2005.22407.x.
5
[Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].[应用抑制剂保护的第三代头孢菌素头孢哌酮/舒巴坦治疗严重医院感染的临床经验]
Antibiot Khimioter. 2005;50(4):33-40.
6
Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam.头孢哌酮舒巴坦引起的急性局限性脓疱性皮疹。
An Bras Dermatol. 2016 Nov-Dec;91(6):808-810. doi: 10.1590/abd1806-4841.20165182.
7
Efficacy and safety of generic cefoperazone/sulbactam versus branded cefoperazone/sulbactam in the treatment of bacterial infections: a systematic review and meta-analysis.国产头孢哌酮/舒巴坦与商品头孢哌酮/舒巴坦治疗细菌感染的疗效和安全性:系统评价和荟萃分析。
J Chemother. 2024 Dec;36(8):698-708. doi: 10.1080/1120009X.2024.2343961. Epub 2024 Apr 21.
8
Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.头孢哌酮-舒巴坦与头孢吡肟治疗医院获得性和医疗相关性肺炎的随机非劣效性试验。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00023-19. Print 2019 Aug.
9
Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.头孢哌酮-舒巴坦治疗腹腔内感染:印度一项随机平行组研究的结果
Surg Infect (Larchmt). 2008 Jun;9(3):367-76. doi: 10.1089/sur.2007.013.
10
Characteristics and Influencing Factors of Coagulation Dysfunction Caused by Cefoperazone/Sulbactam.头孢哌酮/舒巴坦致凝血功能障碍的特点及影响因素
Altern Ther Health Med. 2024 Sep;30(9):274-278.

引用本文的文献

1
Case Report: Anaphylactic shock induced by cefoperazone sodium and sulbactam sodium for injection.病例报告:注射用头孢哌酮钠舒巴坦钠致过敏性休克
Front Med (Lausanne). 2025 Jun 18;12:1579601. doi: 10.3389/fmed.2025.1579601. eCollection 2025.

本文引用的文献

1
Positive experience with TNF-α inhibitor in toxic epidermal necrolysis resistant to high-dose systemic corticosteroids.肿瘤坏死因子-α抑制剂治疗大剂量全身糖皮质激素抵抗的中毒性表皮坏死松解症的阳性经验。
Front Med (Lausanne). 2023 Jul 24;10:1210026. doi: 10.3389/fmed.2023.1210026. eCollection 2023.
2
Biologic TNF-α Inhibitors for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis.用于史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症及中毒性表皮坏死松解症-史蒂文斯-约翰逊综合征重叠综合征的生物肿瘤坏死因子-α抑制剂:一项研究水平和患者水平的荟萃分析
Dermatol Ther (Heidelb). 2023 Jun;13(6):1305-1327. doi: 10.1007/s13555-023-00928-w. Epub 2023 May 13.
3
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients.
国际心肺移植学会(ISHLT)心脏移植受者护理指南。
J Heart Lung Transplant. 2023 May;42(5):e1-e141. doi: 10.1016/j.healun.2022.10.015. Epub 2022 Dec 20.
4
Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center.雪松西奈医疗中心的心脏移植免疫抑制策略
Int J Heart Fail. 2020 Sep 29;3(1):15-30. doi: 10.36628/ijhf.2020.0034. eCollection 2021 Jan.
5
Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:对1980年至2020年PubMed/MEDLINE病例报告的系统评价
Front Med (Lausanne). 2022 Aug 24;9:949520. doi: 10.3389/fmed.2022.949520. eCollection 2022.
6
Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients.药物和医疗状况相关的皮肤不良反应的药物警戒:一项住院患者的回顾性研究。
BMC Pharmacol Toxicol. 2022 Aug 10;23(1):62. doi: 10.1186/s40360-022-00603-4.
7
Cefixime induced Steven Johnson syndrome: A case report from Bangladesh.头孢克肟诱发史蒂文斯-约翰逊综合征:来自孟加拉国的一例病例报告。
Ann Med Surg (Lond). 2022 Jun 28;79:104089. doi: 10.1016/j.amsu.2022.104089. eCollection 2022 Jul.
8
Clinical aspects and therapeutic approach of drug-induced adverse skin reactions in a quaternary hospital: a retrospective study with 219 cases.一家四级医院药物诱导不良皮肤反应的临床方面和治疗方法:一项 219 例回顾性研究。
An Bras Dermatol. 2022 May-Jun;97(3):284-290. doi: 10.1016/j.abd.2021.06.008. Epub 2022 Apr 2.
9
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.全身性治疗史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)和 SJS/TEN 重叠综合征。
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.
10
Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.评价依那西普联合全身皮质类固醇治疗史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的疗效:一项多中心观察性研究。
J Allergy Clin Immunol Pract. 2022 May;10(5):1295-1304.e6. doi: 10.1016/j.jaip.2022.01.038. Epub 2022 Feb 4.